Aldeyra Therapeu (ALDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,090 | -5,187 | 13,061 | N/A | N/A |
| Depreciation Amortization | 55 | 152 | 121 | N/A | N/A |
| Accounts payable and accrued liabilities | 510 | -1 | 269 | N/A | N/A |
| Other Working Capital | 537 | 550 | 260 | N/A | N/A |
| Other Operating Activity | 1,677 | -290 | -15,417 | 0 | 0 |
| Operating Cash Flow | $-9,312 | $-4,776 | $-1,707 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,950 | N/A | N/A | N/A | N/A |
| PPE Investments | -86 | -14 | N/A | N/A | N/A |
| Investing Cash Flow | $-13,036 | $-14 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,396 | 1,000 | N/A | N/A |
| Debt Issued | N/A | N/A | 170 | N/A | N/A |
| Common Stock Issued | 28,506 | 10,055 | 7 | N/A | N/A |
| Other Financing Activity | -36 | -1,396 | 2,568 | 0 | 0 |
| Financing Cash Flow | $28,470 | $10,055 | $3,745 | $N/A | $N/A |
| Beginning Cash Position | 8,527 | 3,262 | 1,224 | N/A | N/A |
| End Cash Position | 14,649 | 8,527 | 3,262 | N/A | N/A |
| Net Cash Flow | $6,122 | $5,265 | $2,039 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,312 | -4,776 | -1,707 | N/A | N/A |
| Capital Expenditure | -86 | -14 | N/A | N/A | N/A |
| Free Cash Flow | -9,398 | -4,790 | -1,707 | 0 | 0 |